FOX BIZ NEWS: Gilead's remdesivir reduces coronavirus mortality risk: Study

Gilead's remdesivir reduces coronavirus mortality risk: Study



Family emergency medicine physician Dr. Janette Nesheiwat applauds President Trump for securing 100 percent of remdesivir for the month of July and 90 percent for August and September since there's now a shortage of the drug.